We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

74 hedge funds and large institutions have $1.01B invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

10,910% more call options, than puts

Call options by funds: $7.38M | Put options by funds: $67K

580% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 5

575% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 4

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

76% more capital invested

Capital invested by funds: $573M → $1.01B (+$434M)

45% more funds holding

Funds holding: 51 → 74 (+23)

Holders
74
Holders Change
+23
Holders Change %
+45.1%
% of All Funds
1.14%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
27
Increased
34
Reduced
5
Closed
4
Calls
$7.38M
Puts
$67K
Net Calls
+$7.31M
Net Calls Change
+$7.31M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$38.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$20.3M
3
State Street
State Street
Massachusetts
+$7.64M
4
Norges Bank
Norges Bank
Norway
+$6.68M
5
FAM
Fred Alger Management
New York
+$5.4M

Top Sellers

Rank Fund Capital Flow
1
CA
CHI Advisors
New York
-$34.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$18.8M
3
SCM
Suvretta Capital Management
New York
-$11.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.23M
5
PA
Perceptive Advisors
New York
-$4.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$4.62M +$2.6M +82,928 +245%
N
27
Nuveen
North Carolina
$4M +$2.75M +87,973 +220%
EI
28
EAM Investors
California
$3.27M +$2.59M +82,764 New
Invesco
29
Invesco
Georgia
$2.44M +$1.94M +61,850 New
EGI
30
EAM Global Investors
California
$2.26M +$1.79M +57,073 New
KCM
31
Kingdon Capital Management
New York
$2.03M +$1.61M +51,332 New
AA
32
ALPS Advisors
Colorado
$1.78M +$1.41M +45,064 New
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$1.56M +$776K +24,800 +169%
Goldman Sachs
34
Goldman Sachs
New York
$1.51M -$4.11M -131,442 -77%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$1.42M +$784K +25,057 +230%
PPA
36
Parametric Portfolio Associates
Washington
$1.35M +$1.07M +34,139 New
AAM
37
AR Asset Management
California
$1.1M +$872K +27,857 New
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.03M +$629K +20,101 +331%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.02M +$805K +25,700 New
DY
40
Dowling & Yahnke
California
$944K +$748K +23,883 New
SEI Investments
41
SEI Investments
Pennsylvania
$845K +$669K +21,374 New
Wells Fargo
42
Wells Fargo
California
$812K +$159K +5,086 +33%
Bank of America
43
Bank of America
North Carolina
$728K +$398K +12,704 +223%
Deutsche Bank
44
Deutsche Bank
Germany
$720K +$367K +11,714 +180%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$700K +$247K +7,882 +80%
LFCM
46
Long Focus Capital Management
Puerto Rico
$665K +$527K +16,824 New
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$651K +$516K +16,471 New
AIG
48
American International Group
New York
$630K +$305K +9,742 +157%
JP Morgan Chase
49
JP Morgan Chase
New York
$591K +$332K +10,606 +244%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$489K +$407K +13,000 New
1
2
3 4

RXDX Hedge Fund Activity: Q4 2021 in Review

74 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q4 2021, worth a combined $1.01B — up 76% from $573M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new RXDX positions and 4 closed out — a net gain of 23 holders — while 34 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $38.2M. The largest seller was CHI Advisors, cutting an estimated $34.7M.

  • 74 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q4 2021, up from 51 in Q3 2021.
  • Funds reported $1.01B of Prometheus Biosciences, Inc. Common Stock stock for Q4 2021, up 76% quarter-over-quarter.
  • 27 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +23 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $38.2M added.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q4 2021 was CHI Advisors, an estimated $34.7M sold.

Based on aggregated 13F filings for Q4 2021.